Merrion Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,400
Closed -$220K 103
2021
Q4
$220K Buy
+2,400
New +$287K 0.16% 93
2021
Q1
Sell
-250
Closed -$50K 216
2020
Q4
$50K Buy
+250
New +$50.8K 0.04% 125

Other funds holding TDOC

Merrion Investment Management's TDOC Position: Q1 2022 in Review

Merrion Investment Management sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 2,400 shares — an estimated $220K sold.

Merrion Investment Management first reported a position in TDOC in Q4 2020 and held it in 2 quarters. The position peaked at $220K in Q4 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Merrion Investment Management reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Merrion Investment Management sold 2,400 Teladoc Health shares in Q1 2022, an estimated $220K.
  • Merrion Investment Management first reported a position in Teladoc Health in Q4 2020 and held it in 2 quarters.
  • Merrion Investment Management's Teladoc Health position peaked at $220K in Q4 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Merrion Investment Management's 13F filing for Q1 2022, filed 13 May 2022.